Bright Minds Biosciences Inc. (DRUG)

Bright Minds Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Year	Current	2023	2022
Market Capitalization	5	6	15
Market Cap Growth	-	-58.67%	-
Enterprise Value	-0	1	6
PE Ratio	-1.26	-1.10	-1.29
PB Ratio	1.02	1.24	1.83
P/FCF Ratio	-1.64	-1.16	-1.42
P/OCF Ratio	-1.64	-1.16	-1.42
EV/EBITDA Ratio	-0.26	-0.19	-0.52
EV/EBIT Ratio	-0.26	-0.19	-0.52
EV/FCF Ratio	-0.33	-0.20	-0.57
Debt / Equity Ratio	-	-	0.01
Debt / EBITDA Ratio	-	-	0.00
Debt / FCF Ratio	-	-	-0.01
Quick Ratio	7.92	24.03	7.92
Current Ratio	8.01	24.26	8.11
Return on Equity (ROE)	-91.70%	-86.10%	-134.00%
Return on Assets (ROA)	-83.50%	-80.00%	-124.50%
Return on Capital (ROIC)	-112.50%	-111.95%	-141.08%
Earnings Yield	-111.85%	-90.48%	-77.64%
FCF Yield	-83.91%	-86.21%	-70.49%
Buyback Yield / Dilution	-7.13%	-50.57%	-37.64%
Total Shareholder Return	-7.13%	-50.57%	-37.64%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).